PMV Pharmaceuticals, Inc. — All Filings
364 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POSASR
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0002006668-26-000002 | Mar 9, 2026 | Mar 5, 2026 |
| 4 | — | 0001613482-26-000002 | Mar 9, 2026 | Mar 5, 2026 |
| 4 | — | 0001825192-26-000002 | Mar 9, 2026 | Mar 5, 2026 |
| 4 | — | 0001341642-26-000002 | Mar 9, 2026 | Mar 5, 2026 |
| S-8 | S-8 | 0001193125-26-095224 | Mar 6, 2026 | — |
| 8-K | 8-K | 0001193125-26-095094 | Mar 6, 2026 | — |
| 10-K | 10-K | 0001193125-26-095014 | Mar 6, 2026 | Dec 31, 2025 |
| SCHEDULE 13D/A | — | 0000947871-26-000231 | Mar 4, 2026 | — |
| SCHEDULE 13G/A | — | 0001172661-26-001163 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001373604-26-000014 | Feb 9, 2026 | — |
| 10-Q | 10-Q | 0001193125-25-276003 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-276000 | Nov 12, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-016264 | Nov 12, 2025 | — |
| 4 | — | 0001341642-25-000004 | Oct 29, 2025 | Oct 27, 2025 |
| 4 | — | 0000947871-25-000927 | Oct 27, 2025 | Oct 23, 2025 |
| SCHEDULE 13D/A | — | 0000947871-25-000926 | Oct 27, 2025 | — |
| 144 | — | 0000947871-25-000922 | Oct 23, 2025 | — |
| SCHEDULE 13G | — | 0001214659-25-014073 | Sep 23, 2025 | — |
| 4 | — | 0000947871-25-000854 | Sep 12, 2025 | Sep 10, 2025 |
| 144 | — | 0000947871-25-000847 | Sep 10, 2025 | — |
| 8-K | 8-K | 0001193125-25-199857 | Sep 10, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-078560 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-011954 | Aug 13, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-104588 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-104587 | Aug 7, 2025 | — |
| 4 | — | 0001415889-25-019386 | Jul 3, 2025 | Jul 1, 2025 |
| 4 | — | 0001415889-25-019384 | Jul 3, 2025 | Jul 1, 2025 |
| 4 | — | 0001415889-25-019382 | Jul 3, 2025 | Jul 1, 2025 |
| 4 | — | 0001415889-25-019380 | Jul 3, 2025 | Jul 1, 2025 |
| 4 | — | 0001415889-25-016276 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016269 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016266 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016262 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016259 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | — | 0001415889-25-016254 | Jun 9, 2025 | Jun 5, 2025 |
| 8-K | 8-K | 0001193125-25-137497 | Jun 9, 2025 | Jun 5, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-049430 | May 15, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-067513 | May 9, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-067511 | May 9, 2025 | — |
| ARS | ARS | 0001140361-25-015613 | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001140361-25-015612 | Apr 25, 2025 | — |
| DEF 14A | DEF 14A | 0001140361-25-015610 | Apr 25, 2025 | Jun 5, 2025 |
| 3 | — | 0001415889-25-011229 | Apr 23, 2025 | Apr 21, 2025 |
| SCHEDULE 13G | — | 0001214659-25-005584 | Apr 8, 2025 | — |
| 4 | — | 0001415889-25-007075 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | — | 0001415889-25-007073 | Mar 5, 2025 | Mar 3, 2025 |
| 4 | — | 0001415889-25-007071 | Mar 5, 2025 | Mar 3, 2025 |
| 10-K | 10-K | 0000950170-25-030414 | Mar 3, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-030407 | Mar 3, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-016122 | Feb 21, 2025 | — |